Catalyst Wire Dossier Catalyst Wire Dossier

FLYSYN

· Synimmune GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FLYSYN, covering 2023-12-28 to 2023-12-28. Get the full timeline:

Most recent: Clinical Trial Update: FLYSYN in MRD Positive AML [Phase 1, Phase 2]

See pricing